Optimizing Y90 Therapy for Radiation Lobectomy

RecruitingOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

July 17, 2020

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
HCCResectionTransplantMetastatic CancerAdult Primary Liver Cancer
Interventions
DEVICE

Y90 radioembolization

Patients with HCC who are eligible to receive standard-of-care Y90 radioembolization and are hepatic resection candidates with inadequate future liver remnant

Trial Locations (1)

60611

RECRUITING

Northwestern University, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mayo Clinic

OTHER

lead

Northwestern University

OTHER